QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Bob Bradway of Amgen bagged a $20.1 million compensation package in 2020, a slight increase from his $19.6 million total the previous year. Pfizer CEO Bourla’s Pay Climbed 17% to $21 Million in 2020 and Gilead Sciences CEO Daniel O’Day earned a $19 million take home. This has to end.

What do future healthcare CEOs look like?

February-Legal-RoundupKEY TAKEAWAY: Median pay for healthcare and pharmaceutical executives amounted to $14.5 million in 2015, higher than for leaders in any other sector , according to Equilar, a California firm that researches and analyzes executive compensation. Median compensation for all CEOs in the study, which looked at pay packages of 341 executives at S&P 500 companies across multiple sectors in 2015, was $10.8 million. The increase in healthcare executive pay from 2014 to 2015 was also greater than in other sectors. Healthcare CEO pay rose 7 percent last year over the amount in 2014, while the comparable median pay increase for all industries was 4.5 percent.